Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1968 1
1990 3
1991 2
1992 2
1993 3
1994 2
1995 1
1997 1
1998 1
1999 2
2000 6
2001 6
2002 6
2003 5
2004 2
2005 7
2006 2
2007 4
2008 7
2009 8
2010 5
2011 4
2012 4
2013 2
2014 2
2015 3
2016 6
2017 5
2018 3
2019 6
2020 2
2021 2
2022 4
2023 2
2024 5

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

117 results

Results by year

Filters applied: . Clear all
Page 1
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis.
Loomba R, Hartman ML, Lawitz EJ, Vuppalanchi R, Boursier J, Bugianesi E, Yoneda M, Behling C, Cummings OW, Tang Y, Brouwers B, Robins DA, Nikooie A, Bunck MC, Haupt A, Sanyal AJ; SYNERGY-NASH Investigators. Loomba R, et al. N Engl J Med. 2024 Jul 25;391(4):299-310. doi: 10.1056/NEJMoa2401943. Epub 2024 Jun 8. N Engl J Med. 2024. PMID: 38856224 Clinical Trial.
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials.
Harrison SA, Wong VW, Okanoue T, Bzowej N, Vuppalanchi R, Younes Z, Kohli A, Sarin S, Caldwell SH, Alkhouri N, Shiffman ML, Camargo M, Li G, Kersey K, Jia C, Zhu Y, Djedjos CS, Subramanian GM, Myers RP, Gunn N, Sheikh A, Anstee QM, Romero-Gomez M, Trauner M, Goodman Z, Lawitz EJ, Younossi Z; STELLAR-3; STELLAR-4 Investigators. Harrison SA, et al. J Hepatol. 2020 Jul;73(1):26-39. doi: 10.1016/j.jhep.2020.02.027. Epub 2020 Mar 6. J Hepatol. 2020. PMID: 32147362 Clinical Trial.
Cinnarizine-induced cholestasis.
Colle I, Reynaert H, Naegels S, Hoorens A, Urbain D. Colle I, et al. Among authors: reynaert h. J Hepatol. 1999 Mar;30(3):553. doi: 10.1016/s0168-8278(99)80121-4. J Hepatol. 1999. PMID: 10190745 No abstract available.
Modelling fatty liver disease with mouse liver-derived multicellular spheroids.
van Os EA, Cools L, Eysackers N, Szafranska K, Smout A, Verhulst S, Reynaert H, McCourt P, Mannaerts I, van Grunsven LA. van Os EA, et al. Among authors: reynaert h. Biomaterials. 2022 Nov;290:121817. doi: 10.1016/j.biomaterials.2022.121817. Epub 2022 Sep 28. Biomaterials. 2022. PMID: 36208587 Free article.
Hepatic circulation.
Geerts A, Timmermans JP, Reynaert H. Geerts A, et al. Among authors: reynaert h. Anat Rec (Hoboken). 2008 Jun;291(6):611-3. doi: 10.1002/ar.20682. Anat Rec (Hoboken). 2008. PMID: 18484605 Free article. No abstract available.
Distal intestinal obstruction in CF patients.
Maus J, Mana F, Reynaert H, Urbain D. Maus J, et al. Among authors: reynaert h. Acta Gastroenterol Belg. 2015 Jan-Mar;78(1):49-52. Acta Gastroenterol Belg. 2015. PMID: 26118577 Free article. Review.
Human iPSC-derived liver co-culture spheroids to model liver fibrosis.
Cools L, Dastjerd MK, Smout A, Merens V, Yang Y, Reynaert H, Messaoudi N, Smet V, Kumar M, Verhulst S, Verfaillie C, van Grunsven LA. Cools L, et al. Among authors: reynaert h. Biofabrication. 2024 Jun 28;16(3). doi: 10.1088/1758-5090/ad5766. Biofabrication. 2024. PMID: 38865994
117 results